Derek Meisner - Jun 15, 2021 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Signature
/s/ Derek M. Meisner
Stock symbol
XFOR
Transactions as of
Jun 15, 2021
Transactions value $
-$32,661
Form type
4
Date filed
6/17/2021, 05:13 PM
Next filing
Jun 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XFOR Common Stock Award $0 +12.5K +19.41% $0.00 76.9K Jun 15, 2021 Direct F1
transaction XFOR Common Stock Sale -$32.7K -4.17K -5.42% $7.84* 72.7K Jun 15, 2021 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units issued to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer and has no expiration date. One third of the shares underlying the restricted stock unit award vested on June 15, 2021. One third of the shares will vest on June 15, 2022, and one third of the shares will vest on June 15, 2023, subject to the Reporting Person providing continuous service to the Issuer on such dates. Shares in respect of the vested portion of the award must be delivered no later than March 15 of the calendar year following the year in which vesting occurs.
F2 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.72 to $8.19, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 Represents unvested restricted stock units.